Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Gossamer Bio: Q2 Earnings Insights

  Gossamer Bio (NASDAQ:GOSS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Gossamer Bio (NASDAQ:GOSS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Gossamer Bio missed estimated earnings by 5.71%, reporting an EPS of $-0.74 versus an estimate of $-0.7.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 0.7% increase in the share price the next day.

 

To track all earnings releases for Gossamer Bio visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For RE/MAX Hldgs

By Benzinga Insights
August 3, 1:13 PM
RE/MAX Hldgs (NYSE:RMAX) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that RE/MAX Hldgs will report an earnings per share (EPS) of $0.64.

RMAX